National Institute of Nursing Research; Notice of Closed Meetings, 3162-3163 [2021-00651]
Download as PDF
<![CDATA[
3162
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of form
Frequency of
response per
respondent
Average time
per response
(in hours)
Total annual
burden hour
Biospecimen Request ......................................................................................
Data Use Annual Progress Report ..................................................................
Biospecimen Use Annual Progress Report .....................................................
Institutional Certification Template ..................................................................
36
60
36
36
1
1
1
1
1
10/60
10/60
5/60
36
10
6
3
Total ..........................................................................................................
200
200
........................
211
Dated: January 5, 2021.
Jennifer M. Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2021–00636 Filed 1–13–21; 8:45 am]
Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669–5069, lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–00577 Filed 1–13–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–00575 Filed 1–13–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; A Solicitation of the
National Institutes of Health (NIH) and the
Centers for Disease Control and Prevention
(CDC) for Small Business Innovation
Research (SBIR) Contract Proposals (N01),
Topic 100.
Date: February 2, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploring Epigenomic or Non-Coding RNA
Regulation in the Development,
Maintenance, or Treatment of Chronic Pain
(R61/R33 Clinical Trial Optional).
Date: February 22, 2021.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
National Institute on Drug Abuse 301 North
Stonestreet Avenue Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Modular Budget Research Project Grant for
NIH Nurse Scientist Scholars.
Date: February 5, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
E:\FR\FM\14JAN1.SGM
14JAN1
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Immunology
(IMM), DPPS, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, RM 4205, Bethesda, MD 20892, (301)
594–0343, yanming@mail.nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Fellowship and Career Development.
Date: February 19, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Immunology
(IMM), DPPS, Center for Scientific Review,
National Institute of Nursing Research,
National Institutes of Health, 6701 Rockledge
Drive, RM 4205 Bethesda, MD 20892, (301)
594–0343, yanming@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–00653 Filed 1–13–21; 8:45 am]
BILLING CODE 4140–01–P
Dated: January 8, 2021.
Tyeshia Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–00651 Filed 1–13–21; 8:45 am]
Prospective Grant of an Exclusive
Patent License: Development and
Commercialization of CD33-Specific
Chimeric Antigen Receptor (CAR)
Therapies for CD33-Expressing
Malignancies Using Natural Killer Cells
(NK Cells) Transduced With Retroviral
or Lentiviral Vectors
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lorna W. Role, Ph.D.,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders and Stroke, 35A Convent Drive,
MSC 3716, Bethesda, MD 20892, lorna.role@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
AGENCY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF
NEUROLOGICAL DISORDERS AND
STROKE, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
SUMMARY:
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: April 11–13, 2021.
Time: 3:00 p.m. to 12:00 p.m.
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
practice the inventions embodied in the
Patents and Patent Applications listed
in the Supplementary Information
section of this Notice to Senti Bio
(‘‘Senti’’), located in South San
Francisco, CA.
DATES: Only written comments and/or
applications for a license which are
received by the National Cancer
Institute’s Technology Transfer Center
on or before January 29, 2021 will be
considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
Exclusive Patent License should be
directed to: Jim Knabb, Senior
Technology Transfer Manager, NCI
Technology Transfer Center at Email:
jim.knabb@nih.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
3163
Intellectual Property
E–097–2018–0: Anti-CD33 Chimeric
Antigen Receptors for Treatment of
Human Acute Myeloid Leukemia
1. US Provisional Patent Application
62/643,015, filed March 14, 2018
(E–097–2018–0–US–01);
2. International Patent Application PCT/
US2019/022,309, filed March 14,
2019 (E–097–2018–0–PCT–02)
3. United Arab Emirates Application
No: P6001291/2020, filed
September 13, 2020 (E–097–2018–
0–AE–03)
4. Australia Application No:
2019235926, filed September 2,
2020 (E–097–2018–0–AU–04)
5. Canada Application No: 3,093,567,
filed September 9, 2020 (E–097–
2018–0–CA–05)
6. China Application No:
201980018105.0, filed September 9,
2020 (E–097–2018–0–CN–06)
7. Eurasia Application No: 202092044,
filed September 25, 2020 (E–097–
2018–0–EA–07)
8. European Patent Application No:
19714007.2, filed October 14, 2020
(E–097–2018–0–EP–08)
9. Israel Application No: 277078, filed
September 1, 2020 (E–097–2018–0–
IL–09)
10. India Application No:
202047039152, filed September 10,
2020 (E–097–2018–0–IN–10)
11. South Korea Application No: 2020–
7029302, filed October 13, 2020 (E–
097–2018–0–KR–11)
12. Mexico Application No: MX/a/2020/
009472, filed September 10, 2020
(E–097–2018–0–MX–12)
13. New Zealand Application No:
767782, filed September 13, 2020
(E–097–2018–0–NZ–13)
14. Saudi Arabia Application No:
520420134, filed September 13,
2020 (E–097–2018–0–SA–14)
15. Singapore Application No:
11202008796V, filed September 9,
2020, (E–097–2018–0–SG–15)
16. United States of America
Application No: 16/980,205, filed
September 11, 2020 (E–097–2018–
0–US–16)
17. South Africa Application No: 2020/
05571, filed September 8, 2020 (E–
097–2018–0–ZA–17)
The patent rights in these inventions
have been assigned and/or exclusively
licensed to the government of the
United States of America.
The prospective exclusive license
territory may be worldwide, and the
fields of use may be limited to the
following:
An exclusive license to:
1. The development of a CD33specific logic-gated CAR-based
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3162-3163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00651]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Nursing Research
Special Emphasis Panel; Modular Budget Research Project Grant for
NIH Nurse Scientist Scholars.
Date: February 5, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Nursing Research, National
Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
[[Page 3163]]
Contact Person: Ming Yan, MD, Ph.D., Scientific Review Officer,
Immunology (IMM), DPPS, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, RM 4205, Bethesda, MD
20892, (301) 594-0343, [email protected].
Name of Committee: National Institute of Nursing Research
Special Emphasis Panel; Fellowship and Career Development.
Date: February 19, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Nursing Research, National
Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ming Yan, MD, Ph.D., Scientific Review Officer,
Immunology (IMM), DPPS, Center for Scientific Review, National
Institute of Nursing Research, National Institutes of Health, 6701
Rockledge Drive, RM 4205 Bethesda, MD 20892, (301) 594-0343,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
Dated: January 8, 2021.
Tyeshia Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-00651 Filed 1-13-21; 8:45 am]
BILLING CODE 4140-01-P
